Literature DB >> 11216858

Cardiac chamber-specific alterations of ANP and BNP expression with advancing age and with systemic hypertension.

V Raizada1, K Thakore, W Luo, P G McGuire.   

Abstract

The present study determined cardiac chamber-specific alterations of the expression of the atrial and brain natriuretic peptide (ANP and BNP) genes with a small increase in age beyond adulthood and with systemic hypertension of intermediate duration. The expression distributions of these genes was determined using in situ hybridization in the right and left atria (RA and LA), and the right and left ventricles (RV and LV) in Wistar Kyoto rats (WKY) and age-matched Spontaneously Hypertensive rats (SHR) at ages 6 months (adult) and 8 months (advanced-age beyond adulthood). In all rat groups, both genes were expressed (ANP > BNP) in the LA and LV, and were not expressed in the RA and RV. The genes were expressed in the LA in all rat groups; the ANP, but not the BNP, expression increased with advancing age and with superimposed hypertension. They were expressed in the LV of the advanced-age WKY, adult and advanced-age SHR, but not in the adult WKY. The ANP mRNA labeling in the LA was diffuse and interspersed with dense accumulations, whereas BNP labeling was diffuse. The labeling of both genes in the form of sparse clusters was seen in the LV of the advanced-age SHR. Our study showed that ANP and BNP expression in left heart chambers increased with a small increase in age, with hypertension of intermediate duration, and with modest left ventricular hypertrophy. The chamber-specific expression distribution could be due to special groups of cardiac cells, or to local chamber-specific factors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11216858     DOI: 10.1023/a:1011027231702

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  12 in total

Review 1.  Cardiovascular regulatory mechanisms in advanced age.

Authors:  E G Lakatta
Journal:  Physiol Rev       Date:  1993-04       Impact factor: 37.312

2.  Ventricular expression of atrial and brain natriuretic peptides in dilated cardiomyopathy. An immunohistocytochemical study of the endomyocardial biopsy specimens using specific monoclonal antibodies.

Authors:  K Hasegawa; H Fujiwara; K Doyama; M Mukoyama; K Nakao; T Fujiwara; H Imura; C Kawai
Journal:  Am J Pathol       Date:  1993-01       Impact factor: 4.307

3.  Myocyte cell loss and myocyte cellular hyperplasia in the hypertrophied aging rat heart.

Authors:  P Anversa; T Palackal; E H Sonnenblick; G Olivetti; L G Meggs; J M Capasso
Journal:  Circ Res       Date:  1990-10       Impact factor: 17.367

4.  Localized endocrine conversion of ventricular cardiocytes in ventricular aneurysm.

Authors:  J Gu; L B McGrath
Journal:  J Histochem Cytochem       Date:  1990-11       Impact factor: 2.479

5.  Ventricular expression of brain natriuretic peptide in hypertrophic cardiomyopathy.

Authors:  K Hasegawa; H Fujiwara; K Doyama; M Miyamae; T Fujiwara; S Suga; M Mukoyama; K Nakao; H Imura; S Sasayama
Journal:  Circulation       Date:  1993-08       Impact factor: 29.690

6.  Passive mechanical stretch releases atrial natriuretic peptide from rat ventricular myocardium.

Authors:  P Kinnunen; O Vuolteenaho; P Uusimaa; H Ruskoaho
Journal:  Circ Res       Date:  1992-06       Impact factor: 17.367

7.  Cellular mechanisms for synthesis and secretion of atrial natriuretic peptide and brain natriuretic peptide in cultured rat atrial cells.

Authors:  E Suzuki; Y Hirata; O Kohmoto; T Sugimoto; H Hayakawa; H Matsuoka; T Sugimoto; M Kojima; K Kangawa; N Minamino
Journal:  Circ Res       Date:  1992-11       Impact factor: 17.367

8.  Cellular localization and structural characterization of natriuretic peptide-expressing ventricular myocytes from patients with dilated cardiomyopathy.

Authors:  M Tanaka; M Hiroe; T Nishikawa; T Sato; F Marumo
Journal:  J Histochem Cytochem       Date:  1994-09       Impact factor: 2.479

9.  Atrial natriuretic factor in the impulse-conduction system of rat cardiac ventricles.

Authors:  M Cantin; G Thibault; H Haile-Meskel; J Ding; R W Milne; M Ballak; C Charbonneau; M Nemer; J Drouin; R Garcia
Journal:  Cell Tissue Res       Date:  1989       Impact factor: 5.249

10.  Inhibition of urokinase synthesis and cell surface binding alters the motile behavior of embryonic endocardial-derived mesenchymal cells in vitro.

Authors:  P G McGuire; S M Alexander
Journal:  Development       Date:  1993-07       Impact factor: 6.868

View more
  11 in total

1.  N-Terminal-proBNP (NT-proBNP) as an indicator of cardiac dysfunction. A study in patients presenting with suspected cardiac disorders.

Authors:  G Hess; J Moecks; D Zdunek
Journal:  Z Kardiol       Date:  2005-04

2.  Pro-B-type natriuretic peptide(1-108) circulates in the general community: plasma determinants and detection of left ventricular dysfunction.

Authors:  Fima Macheret; Guido Boerrigter; Paul McKie; Lisa Costello-Boerrigter; Brian Lahr; Denise Heublein; Sharon Sandberg; Yasuhiro Ikeda; Alessandro Cataliotti; Kent Bailey; Richard Rodeheffer; John C Burnett
Journal:  J Am Coll Cardiol       Date:  2011-03-22       Impact factor: 24.094

3.  Molecular signature of a right heart failure program in chronic severe pulmonary hypertension.

Authors:  Jennifer I Drake; Herman J Bogaard; Shiro Mizuno; Berrick Clifton; Bin Xie; Yuan Gao; Catherine I Dumur; Paul Fawcett; Norbert F Voelkel; Ramesh Natarajan
Journal:  Am J Respir Cell Mol Biol       Date:  2011-06-30       Impact factor: 6.914

4.  Relation of N-terminal pro-B-type natriuretic peptide with diastolic function in hypertensive heart disease.

Authors:  Imran Uraizee; Susan Cheng; Chung-Lieh Hung; Anil Verma; James D Thomas; Michael R Zile; Gerard P Aurigemma; Scott D Solomon
Journal:  Am J Hypertens       Date:  2013-06-22       Impact factor: 2.689

5.  Sex-specific differences in natriuretic peptide and nitric oxide synthase expression in ANP gene-disrupted mice.

Authors:  Philip G Wong; David W J Armstrong; M Yat Tse; Emily P A Brander; Stephen C Pang
Journal:  Mol Cell Biochem       Date:  2012-11-21       Impact factor: 3.396

6.  The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population.

Authors:  I Raymond; B A Groenning; P R Hildebrandt; J C Nilsson; M Baumann; J Trawinski; F Pedersen
Journal:  Heart       Date:  2003-07       Impact factor: 5.994

7.  Association between resting heart rate and N-terminal pro-brain natriuretic peptide in a community-based population study in Beijing.

Authors:  Ruihua Cao; Yongyi Bai; Ruyi Xu; Ping Ye
Journal:  Clin Interv Aging       Date:  2014-12-18       Impact factor: 4.458

8.  NT-proBNP, C-reactive protein and soluble uPAR in a bi-ethnic male population: the SAfrEIC study.

Authors:  Ruan Kruger; Rudolph Schutte; Hugo W Huisman; Peter Hindersson; Michael H Olsen; Jesper Eugen-Olsen; Aletta E Schutte
Journal:  PLoS One       Date:  2013-03-13       Impact factor: 3.240

9.  Prognostic value of N-terminal pro-brain natriuretic peptide in elderly people with acute myocardial infarction: prospective observational study.

Authors:  L Lorgis; M Zeller; G Dentan; P Sicard; P Buffet; I L'Huillier; J C Beer; M Vincent-Martin; H Makki; P Gambert; Y Cottin
Journal:  BMJ       Date:  2009-05-06

10.  Inverse association of N-terminal pro-B-type natriuretic peptide with metabolic syndrome in patients with congestive heart failure.

Authors:  Huai-Ren Chang; Jen-Che Hsieh; Bang-Gee Hsu; Ling-Yi Wang; Michael Yu-Chih Chen; Ji-Hung Wang
Journal:  PLoS One       Date:  2013-11-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.